Major pharmaceutical companies are already investing in U.S. manufacturing: Guggenheim's Divan

Your next guest says that these tariffs could potentially have a big impact, but for now he's still bullish on the group overall. So, Vaml Devon is senior farmer analyst at Guggenheim Partners joins us now. Vaml, it's great to have you.>> Yeah, thanks so much for having me. >> Okay, so devil's in the details as I said before the break uh on these tariffs. How many of these big pharmaceutical giants are already building out manufacturing capability here in the US.>> Yeah, almost all of them honestly. So I th ...